A44: High Levels of DEK Autoantibodies May Predict Early Flare Following Cessation of Anti‐TNF Therapy
Nirit Mor‐Vaknin(University of Michigan), David M. Markovitz(University of Michigan), Sampath Prahalad(Emory University), Michael Shishov(Phoenix Children's Hospital), Miguel Rivas(University of Michigan), Anne Johnson(Cincinnati Children's Hospital Medical Center), Cynthia Yuanfan Ye(University of Michigan), Maureen Legendre(University of Michigan), Timothy Beukelman(University of Alabama at Birmingham), Bin Huang(Cincinnati Children's Hospital Medical Center), Lawrence Jung(Creighton University), Daniel J. Lovell(Cincinnati Children's Hospital Medical Center), Beth S. Gottlieb, Judyann C. Olson(Medical College of Wisconsin), Kara Schmidt(University of Münster), Paula Morris(Boston Children's Hospital), Karen Onel(Hospital for Special Surgery), Barbara Edelheit(Connecticut Children's Medical Center), Lili Zhao(University of Michigan), Jay Mehta(Sardar Patel University), Edward H. Giannini(Cincinnati Children's Hospital Medical Center), Murray H. Passo(Cincinnati Children's Hospital Medical Center), Yuki Kimura(Jichi Medical University), Steven J. Spalding(Cleveland Clinic), Elaine Cassidy(Children's Hospital of Pittsburgh)
Cited by 1
Related Papers
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
|Nature Genetics|2009|1.4k